Summary
For the development of effective prophylaxis (hyperimmune globulins) and improvement of serological testing for human cytomegalovirus (HCMV) infection in immunocompromised patients it is essential to characterize the viral encoded proteins and the humoral immune response in terms of neutralizing antibodies and immunglobulin class and IgG subclass reactivity to “early” and “late” HCMV proteins. The major neutralizing epitopes have been identified and screening of donor sera for neutralizing antibody by either conventional neutralization assays or enzyme-linked immunosorbent assay using recombinant antigens may help to improve the efficacy of hyperimmune globulin prophylaxis. The humoral response to individual HCMV proteins has been thoroughly investigated in immunocompromised patients. Antibodies against HCMV induced “early” antigens are not exclusively associated with active infection but may indicate an elevated risk for cytomegalic inclusion disease in immunocompromised patients. With a sensitive western blot technique. IgM and IgA antibodies against HCMV “late” proteins can be detected in sera from healthy seropositive individuals. Serum samples from subjects suffering from cytomegalic inclusion disease show significantly larger broader immune responses compared with healthy HCMV antibody carriers. Promising results using recombinant antigens corresponding to immunodominant epitopes for the detection of HCMV specific antibodies have been published.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- AIDS:
-
acquired immunodeficiency syndrome
- CID:
-
cytomegalic inclusion disease
- ELISA:
-
enzyme linked immunosorbent assay
- HCMV:
-
human cytomegalovirus
- PCR:
-
polymerase chain reaction
References
Andersen P, Andersen KK (1975) Smooth muscle antibodies and other tissue antibodies in cytomegalovirus infection. Clin Exp Immunol 22:22–29
Arraull-Cruz TP, Ho M, Armstrong JA (1978) A protective effect of early serum from mice after cytomegalovirus infection. Infect Immun 21:840–842
Banks T, Tuo B, Kousoulas K, Spaete R, Pachl C, Pereira L (1989) A major neutralizing domain maps within the carboxyterminal half of the cleaved cytomegalovirus B glycoprotein. J Gen Virol 70:979–985
Blanton RA, Tevethia MA (1981) Immunoprecipitation of virus-specific immediate early and early polypeptides from cells lytically infected with human cytomegalovirus strain AD-169. Virology 112:262–273
Bowden RA, Sayers M, Fluornoy N, Newton B, Banaji M, Thomas ED, Meyers JD (1986) Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation. N Engl J Med 314:1006–1010
Bowden RA, Fischer LD, Rogers K, Cays M, Meyers JD (1991) Cytomegalovirus (CMV)-specific intravenous immunoglobulin for the prevention of primary CMV infection and disease after marrow transplant. J Infect Dis 164:483–487
Braun W, Abraham R (1989) Modified diffusion blotting for rapid and efficient protein transfer with PhastSystem. Electrophoresis 10:249–253
Braun W, Doerr HW (1991) Neutralisierende Antikörper bei Zytomegalie. Münchner Med Wochenschr 133:360–362
Braun W, Schacherer C (1988) Rapid (24 h) neutralization assay for the detection of antibodies to human cytomegalovirus using a monoclonal antibody to an HCMV early nuclear protein. J Virol Methods 22:31–40
Braun W, Weber B, Moell U, Doer HW (1993) Immunoglobulin A and M patterns to human cytomegalovirus during recurrent infection in AIDS patients studied by western blot. J Virol Methods (in press)
Britt WJ (1984) Neutralizing antibodies detect a di-sulfidelinked glycoprotein complex within the envelope of human cytomegalovirus. Virology 135:369–378
Britt WJ, Vugler L, Butfiloski EJ, Stephens EB (1990) Cell surface expression of human cytomegalovirus (HCMV) gp55–116 (gB): use of HCMV-recombinant vaccinia virus-infected cells in analysis of the human neutralizing antibody response. J Virol 64:1079–1085
Chanarin I, Walford D (1973) Thrombocytopenic purpura in cytomegalovirus mononucleosis. Lancet II:238–239
Chou SW (1989) Neutralizing antibody responses to re-infecting strains of cytomegalovirus in transplant recipients. J Infect Dis 160:16–21
Cranage MP, Kouzarides T, Bankier AT, Satchwell S, Weston K, Tomlinson P, Barrell B, Hart H, Bell SE, Minson AC, Smith GL (1987) Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus. EMBO J 5:3057–3063
Doerr HW, Braun W (1991) Analyse der Antikörper gegen das Zytomegalievirus des Menschen (HCMV) als Pathogenizitätsmarker. In: Deinhardt F, Maass G, Spiess H (eds) Neues in der Virusdiagnostik. Deutsches Grünes Kreuz, Marburg, S563
Doerr HW, Rentschler M, Scheifler G (1987) Serologic detection of active infections with human herpesviruses (CMV, EBV, HSV, VZV): diagnostic potential of IgA class and IgG subclass specific antibodies. Infection 15:93–98
Doerr HW, Hamann A, Weber B (1991) Role of human cytomegalovirus (HCMV) serodiagnosis in blood transfusion and organ transplantation. Biotest Bulletin 4:299–302
Friedman AD, Furukawa T, Plotkin SA (1982) Detection of antibody to cytomegalovirus early antigen in vaccinated, normal volunteers and renal transplant candidates. J Infect Dis 146:255–259
Friedman AD, Michelson S, Plotkin SA (1982) Detection of antibodies to pre-early nuclear antigen and immediate-early antigens in patients immunized with cytomegalovirus vaccine. Infect Immun 38:1068–1072
Gerna G, Cereda PM, Cattaneo E, Achilli G, Revello G (1978) Immunoglobulin G to virus-specific early antigens in congenital, primary and reactivated human cytomegalo-virus infections. Infect Immun 22:833–841
Gilljam G, Wahren B (1985) Properties of IgG subclasses to human cytomegalovirus. J Virol Methods 25:139–152
Gold D, Ashley R, Handsfield HH (1988) Immunoblot analysis of the humoral immune response in primary cytomegalovirus infection. J Infect Dis 157:319–326
Griffiths PD, Buie KJ, Heath RB (1980) Persistence of high titer antibodies to early antigens of cytomegalovirus in pregnant women. Arch Virol 64:303–309
Hamann A, Braun W, Doerr HW (1991) Antibodies against human CMV-induced “early” antigens detected by immunoblotting are not exclusively associated with active infection. Res Virol 142:33–37
Hamann A, Doerr HW (1991) IgG subclass-specific antibodies to human cytomegalovirus (HCMV)-induced early antigens. Med Microbiol Immunol 180:193–204
Hayes K, Alford C, Britt W (1987) Antibody response to virus-encoded proteins after cytomegalovirus mononucleosis. J Infect Dis 156:615–621
Jahn G, Scholl VC, Traupe B, Fleckenstein B (1987) The two major phosphoproteins (pp65 and pp150) of human cytomegalovirus and their antigenic properties. J Gen Virol 68:1327–1337
Joassin L, Somze A, Reginster M (1989) Detection by enzyme-linked immunosorbent assay of specific immunoglobulin G isotypes in primary and established cytomegalovirus infections. J Clin Microbiol 27:139–144
Kniess N, Mach M, Fay J, Britt WJ (1991) Distribution of linear antigenic sites on glycoprotein gp55 of human cytomegalovirus. J Virol 65:138–146
Kosinowsky UH (1991) Molecular analysis of cytomegalovirus pathogenesis and immunological control (abstract). Third Joint Meeting of the European Group of Rapid Viral Diagnosis and the Society against Virus Diseases, Strasbourg, OS 15
Landini MP, Baldassarri B, Mirolo G, Ripalti A, La Placa M (1988) Reactivity of cytomegalovirus structural polypeptides with different subclass of IgG present in human sera. J Infect 16:163–167
Landini MP, Michelson S (1988) Human cytomegalovirus proteins. In: Melnick JL (ed) Progress in medical virology, vol 35. Basel, Karger, pp 152–185
Landini MP, Re Mc, Mirolo G, Baldassari B, La Placa M (1985) Human immune response to cytomegalovirus structural polypeptides studied by immunoblotting. J Med Virol 17:303–311
Landini MP, Mirolo G, Coppolecchia P,Re MC, La Placa M (1986) Serum antibodies to individual cytomegalovirus structural polypeptides in renal transplant recipients during viral infection. Microbiol Immunol 30:683–695
Landini MP, Severi B, Furlini G, Badiali L (1987) Human cytomegalovirus structural components: intracellular and intraviral localization of p28 nd p65/69 by immunelectronmicroscopy. Virus Res 8:15–23
Landini MP, Rossier E, Schmitz H (1988) Antibodies to human cytomegalovirus structural polypeptides during primary infection. J Virol Methods 22:309–317
Landini MP, Lazzarotto T, Ripalti A, Guan MX, LaPlaca M (1989) Antibody response to recombinant lambda gt11 fusion proteins in cytomegalovirus infection. J Clin Microbiol 27:2324–2327
Landini MP, Guan MX, Jahn G, Lindenmaier W, Mach M, Ripalti A, Necker A, Lazzarotto T, Plachter B (1990) Large-scale screening of human sera with cytomegalovirus recombinant antigens. J Clin Microbiol 28:1375–1379
Landini MP, Lazzarotto T, Percivalle E,Ripalti A, Gerna S (1991) Evidence that human cytomegalovirus assembly proteins share antigenic sites with an uninfected cell membrane protein: In: Progress in cytomegalovirus research. Proceedings of the Third International Cytomegalovirus Workshop, Bologna, 11–14 June 1991. Elsevier, Amsterdam, pp 161–168
Linde A, Hammarstroem L, Persson MA, Smith CI, Sundqvist VA, Wahren B (1983) Virus-specific antibody activity of different subclasses of immunoglobulins G and A in cytomegalovirus infections. Infect Immunity 42:237–244
Mach M, Britt W (1991) Immunoprophylaxis of human cytomegalovirus infections. In: Landini MP (ed): Progress in cytomegalovirus research. Proceedings of the Third International Cytomegalovirus Workshop, Bologna, 11–14 June 1991. Elsevier, Amsterdam, pp 175–186
Marsano L, Perrillo RP, Wayne Flye M, Hanto DW, Spitzer ED (1990) Comparison of culture and serology for the diagnosis of cytomegalovirus infection iin kidney and liver transplant recipients. J Infect Dis 161:454–461
McKeating JA, Griffiths PD, Grundy JE (1987) Cytomegalovirus in urine specimens has host β2 microglobulin bound to the viral envelope: a mechanism of evading the host immune response? J Gen Virol 68:785–792
McVoy MA, Adler SP (1989) Immunologic evidence for frequent age-related cytomegalovirus reactivation in seropositive immunocompetent individuals. J Infect Dis 160:110
Meyer H, Bankier AT, Landini MP, Brown CM, Barrell BG, Rüger B, Mach M (1988) Identification and procaryotic expression of the gene coding for the highly immunogenic 28-kilodalton structural phosphoprotein (pp28) of human cytomegalovirus. J Virol 62:2243–2250
Michelson S, Tardy-Panit M, Colimon R, Landini MP (1989) A human cytomegalovirus-neutralizing monoclonal antibody recognizes a normal cell protein. J Gen Virol 70:673–684
Middeldorp JM, Jongsma J, Ter Haar A, Schirm J, The TH (1984) Detection of immunoglobulin M and G antibodies against cytomegalovirus early and late antigens by enzyme-linked immunosorbent assay. J Clin Microbiol 20:763–771
Musiani M, Landini MP, Feletti C, LaPlaca M (1978) Serum antibodies against cytomegalovirus-induced “early” and “immediate early” antigens and presence of viruria in renal transplant recipients. Microbiologica 1:101–105
Opp M, Doerr HW (1991) Erfahrungen mit der Polymerase Chain Reaction (PCR) zum Nachweis der Zytomegalievirus-DNA. Ärztl Lab 37:75–78
Pereira L, Hoffmann M, Cremer N (1982) Electrophoretic analysis of polypeptides immune precipitated from cytomegalovirus-infected cell extracts by human sera. Infect Immun 36:933–942
Plachter B, Wieczorek L, Scholl BC, Ziegelmaier R, Jahn G (1992) Detection of cytomegalovirus antibodies by an enzyme-linked immunosorbent assay using recombinant polypeptides of the large phosphorylated tegument protein pp150. J Clin Microbiol 30:201–206
Porath A, Hanuka N, Keynan A, Sarov I (1987) Virusspecific serum IgG, IgM, and IgA antibodies in cytomegalovirus mononucleosis patients as determined by immunoblotting technique. J Med Virol 22:223–230
Prentice HG (1989) Prophylaxis and treatment of cytomegalovirus infections in the bone marrow transplant recipient. J Antimicrobiol Chemother 23:23–30
Ripalti A, Landini MP, Mocarski ES, La Placa M (1989) Identification and preliminary use of recombinant lambda gt11 fusion proteins in cytomegalovirus diagnosis. J Gen Virol 70:1247–1251
Schanley JD, Jordan MC, Stevens JG (1981) Modification by adoptive Immoral immunity of marine cytomegalovirus infection. J Infect Dis 143:231–237
Schmitz H, Essuman S (1986) Comparison of the neutralizing and ELISA antibody titres to human cytomegalovirus (HCMV) in human sera and in gamma globulin preparations. J Med Virol 20:177–182
Schmitz H, Müller-Lantzch N, Peteler G (1980) Human immune response to proteins of cytomegalovirus. Intervirology 13:154–161
Scholl BC, Von Hintzenstern J, Borish B, Traupe B, Broker M, Jahn G (1988) Procaryotic expression of immunogenic polypeptides of the large phosphoprotein (ppl50) of human cytomegalovirus. J Gen Virol 69:1195–1204
Stinski MF (1977) Synthesis of proteins and glycoproteins in cells infected with human cytomegalovirus. J Virol 23:751–767
Sundqvist VA, Linde A, Kurth R, Werner A, Helm EB, Popovic M, Gallo RC, Wahren B (1986) Restricted IgG subclass responses to HTLV-III/LAV and to cytomegalovirus in patients with AIDS and lymphadenopathy syndrome. J Infect Dis 153:970–973
The TH, Andersen HK, Spencer ES, Klein G (1977) Antibodies against cytomegalovirus-induced early antigens (CMV-EA) in immunosuppressed renal-allograft recipients. Clin Exp Immunol 28:502–505
Utz U, Britt W, Vugler L, Mach M (1989) Identification of neutralizing epitope on glycoprotein gp58 of human cytomegalovirus. J Virol 63:1995–2001
Van der Bij W, Torensma R, Van Son WJ, Anema J, Schirm J, Tegzess AM, The TH (1988) Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leucocytes. J Med Virol 25:179–188
Van Loon AM, Heessen FWA, van der Logt JTM (1987) Antibody isotype response after human cytomegalovirus infection. J Virol Methods 15:101–107
Wagner O, Rasanen JA, Hagman A, Klemola E (1968) Mixed cryoimmunoglobulinemia in infectious mononucleosis and cytomegalovirus mononucleosis. Int Arch Allergy AppI Immunol 35:345–361
Wahren B, Linde A, Sundqvist VA, Ljundman P, Lönngvist B, Ringdén O (1984) IgG-subclass-specific CMV reactivity in bone marrow transplant recipients. Transplantation 38:479–483
Weber B, Braun W, Tyralla B, Doerr HW (1992) Human cytomegalovirus (HCMV) specific IgE in primary HCMV infection. Clin Investig 70:497–502
Weber B, Hamann A, Ritt B, Rabenaú H, Doerr W (1992) Comparison of shell vial culture and serology for the diagnosis of human cytomegalovirus infection in neonates and immunocompromised subjects. Clin Investig 70:503–507
Weber B, Klinghardt U, Lux A, Braun W, Rabenau H, Doerr HW (1993) Detection of neutralizing antibodies against human cytomegalovirus (HCMV): influence of strain variation. J Med Virol (in press)
Weber B, Opp M, Born HJ, Langenbeck U, Doerr HW (1992) Laboratory diagnosis of congenital human cytomegalovirus infection using PCR and shell vial culture: a case report. Infection 20:155–157
Zaia JA, Forman SJ, Ting YP, Vanderwal-Urbina E, Blume KG (1985) Polypeptide-specific antibody response to human cytomegalovirus after infection in bone marrow transplant recipients. J Infect Dis 153:780–787
Zeuler WW, Stulberg CS, Page RH, Teruya J, Brough AJ (1966) Etiology and pathogenesis of acquired hemolytic anemia. Transfusion 6:438–461
Author information
Authors and Affiliations
Additional information
Dedicated to Prof Dr. K. Munk, Heidelberg, on the occasion of his 70th birthday
Rights and permissions
About this article
Cite this article
Weber, B., Braun, W., Cinatl, J. et al. Humoral immune response to human cytomegalovirus infection: diagnostic potential of immunoglobulin class and IgG subclass antibody response to human cytomegalovirus early and late antigens. Clin Investig 71, 270–276 (1993). https://doi.org/10.1007/BF00184725
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00184725